| Dr Douglas Barrett Tamkin, MD | |
|
6200 Wilshire Blvd, Suite 1206, Los Angeles, CA 90048 | |
| (323) 939-2111 | |
| (323) 965-8640 |
| Full Name | Dr Douglas Barrett Tamkin |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 6200 Wilshire Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952423659 | NPI | - | NPPES |
| G12583 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | G12583 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Barrett Tamkin, MD 6200 Wilshire Blvd, Suite 1206, Los Angeles, CA 90048 Ph: (323) 939-2111 | Dr Douglas Barrett Tamkin, MD 6200 Wilshire Blvd, Suite 1206, Los Angeles, CA 90048 Ph: (323) 939-2111 |
News Archive
A dozen nurses say the University of Medicine and Dentistry of New Jersey violated laws by mandating they help with abortion patients. Meanwhile, Regions Hospital in St. Paul will stop providing abortions in December.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Agilent Technologies Inc. today announced it has been selected by the South African Doping Control Laboratory as the primary provider of gas-phase testing instruments for the 2010 World Cup. The South African Doping Control Laboratory is certified by the World Anti-Doping Agency and will be responsible for all doping testing during the competition.
Abraxis BioScience, Inc. today announced that its randomized registrational Phase 3 clinical trial comparing ABRAXANE® (protein-bound paclitaxel) with Taxol® (paclitaxel) injection, both in combination with carboplatin, met the study's primary endpoint by demonstrating that ABRAXANE showed a significant improvement in overall response rate as compared to Taxol, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), as assessed by independent radiologist review.
› Verified 6 days ago
Dr. Robert W Eitches, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8631 W 3rd St, 925e, Los Angeles, CA 90048 Phone: 310-657-4600 Fax: 310-657-6020 | |
Renata G. Lubens, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Dr. Barry Allen Kohn, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 7095 Hollywood Blvd, #635, Los Angeles, CA 90028 Phone: 323-436-0516 Fax: 323-436-0517 | |
Dr. Jean Marie Hanley, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1801 E. Marengo St., L-902, Los Angeles County Usc Division Of Allergy, Los Angeles, CA 90033 Phone: 323-226-3823 Fax: 323-226-3732 | |
Richard M Harris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1125 S Beverly Dr, Suite 740, Los Angeles, CA 90035 Phone: 310-275-0380 Fax: 310-275-1210 | |
Christina Hong Lee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11301 Wilshire Blvd, Bldg 500, 111r, Los Angeles, CA 90073 Phone: 310-478-3711 | |
Emily Hao-yun Liang, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4733 W Sunset Blvd, 3rd Floor, Los Angeles, CA 90027 Phone: 323-783-4516 |